Clinical Trials · NCT00402337
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Enrollment
- 310
- Start date
- Nov 2006
- Locations
- 60 sites, United States
- Primary endpoint
- Change From Pretreatment in Weekly Normalized Spontaneous Bowel Movement (SBM) Frequency